Syndax Pharmaceuticals (SNDX) Insider & Congress Trades

Smart money at a glance

Filings to Nov 9, 2026

Net selling: insiders sold $114K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: -$114K net
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Jun 30, 2026: 1 added, 1 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about SNDX filings

Are insiders buying or selling Syndax Pharmaceuticals Inc (SNDX) stock?

Net selling: insiders sold $114K and bought $0 of SNDX stock on the open market in the 90 days to Nov 9, 2026, according to SEC Form 4 filings. $114K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Podlesak, Dennis (Director), who sold $114K. The latest filing was on Oct 30, 2026.

Which members of Congress have traded SNDX recently?

None. No member of Congress disclosed a SNDX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SNDX smart-money data?

This summary uses filings available on Nov 9, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on SNDX

Lean short2 sources:
- Insiders
- Funds

Top traders
No tracked positions at the last update
Insiders
Lean short3 sales · $2.1M
3 of 3 on scheduled plans. Form 4 filings.
Politicians
No recent politician filings found
Funds
Lean short1 added · 2 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about SNDX filings

Are insiders buying or selling Syndax Pharmaceuticals Inc (SNDX) stock?

Which members of Congress have traded SNDX recently?

None. No member of Congress disclosed a SNDX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SNDX smart-money data?

Funds

What funds are doing

3 moves · 6 mo

Buys/Adds$40.2MSells/Trims$102.6M

Buys/Adds (1)

MI
Millennium
Israel Englander · Q2 2026 13F
$40.2M
added
Signals like this: n=13773, 53% finished lower at D15, median -0.4% vs SPY -0.4%

Sells/Trims (2)

P7
Point72
Steven Cohen · Q2 2026 13F
$46.4M
sold
Signals like this: n=2238, 53% finished lower at D15, median -0.5% vs SPY -0.4%
P7
Point72
Steven Cohen · Q1 2026 13F
$56.2M
trimmed
Signals like this: n=7469, 53% finished lower at D15, median -0.5% vs SPY -0.4%

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 2, 2026

Earnings came in 13.7% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 2, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.55-13.69% miss

-$0.48 expected

Revenue

$83.3M

SEC filing

EPS: Yahoo Finance

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 2, 2026	-$0.55est. -$0.48	-13.69%miss	$83.3MSEC filing	+81.6%from $45.9M
Jun 30, 2026Reported Aug 4, 2026	-$0.55est. -$0.45	-22.22%miss	$72.8MSEC filing	+91.8%from $38.0M
Mar 31, 2026Reported Apr 30, 2026	-$0.48est. -$0.59	+18.76%beat	$64.9MSEC filing	+223.6%from $20.0M
Dec 31, 2025Reported Feb 26, 2026	-$0.78est. -$0.64	-21.88%miss	$172.4M · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 3, 2025	-$0.70est. -$0.71	+1.54%beat	$45.9MSEC filing	+267.0%from $12.5M
Jun 30, 2025Reported Aug 4, 2025	-$0.83est. -$1.01	+17.82%beat	$38.0MSEC filing	+984.5%from $3.5M
Mar 31, 2025Reported May 5, 2025	Not on file	No estimate	$20.0MSEC filing	No year-ago quarter
Dec 31, 2024Reported Mar 3, 2025	-$1.10est. -$0.23	-$0.87miss	$23.7M · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $9.59
High: $9.78
Low: $9.22
Prev close: $9.37
52-wk high: $25.59
52-wk low: $9.22
Mkt cap: $858.9M
ROE: -426.4%
Beta: 0.45
P/S: 3.0x
P/B: 84.8x
Profit margin: -72.3%
Op margin: -50.3%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -72.3%
Market cap: $859M

Valuation

P/S2.96
P/B84.75

Quality

Operating margin-50.3%
ROE-426.4%
ROA-17.9%

Growth

Beta0.45

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

32balanced

20D volatility

138%annualized

52-week range

$9.54

$9.22$25.59

20D support

$9.22recent floor

20D resistance

$16.95recent ceiling

Returns

5D -30.1%20D -43.8%60D -50.0%

Price vs moving averages

SMA20 -27.4%SMA50 -41.6%SMA200 -52.3%

Volume pace

2.11xvs prior 20D

Smart money at a glance

Filings to Nov 9, 2026

Net selling: insiders sold $114K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: -$114K net
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Jun 30, 2026: 1 added, 1 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about SNDX filings

Are insiders buying or selling Syndax Pharmaceuticals Inc (SNDX) stock?

Which members of Congress have traded SNDX recently?

None. No member of Congress disclosed a SNDX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SNDX smart-money data?

13F: filed up to 45 days late.

Smart money on SNDX

Lean short2 sources:
- Insiders
- Funds

Top traders
No tracked positions at the last update
Insiders
Lean short3 sales · $2.1M
3 of 3 on scheduled plans. Form 4 filings.
Politicians
No recent politician filings found
Funds
Lean short1 added · 2 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about SNDX filings

Are insiders buying or selling Syndax Pharmaceuticals Inc (SNDX) stock?

Which members of Congress have traded SNDX recently?

None. No member of Congress disclosed a SNDX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SNDX smart-money data?

Funds

What funds are doing

3 moves · 6 mo

Buys/Adds$40.2MSells/Trims$102.6M

Buys/Adds (1)

MI
Millennium
Israel Englander · Q2 2026 13F
$40.2M
added
Signals like this: n=13773, 53% finished lower at D15, median -0.4% vs SPY -0.4%

Sells/Trims (2)

P7
Point72
Steven Cohen · Q2 2026 13F
$46.4M
sold
Signals like this: n=2238, 53% finished lower at D15, median -0.5% vs SPY -0.4%
P7
Point72
Steven Cohen · Q1 2026 13F
$56.2M
trimmed
Signals like this: n=7469, 53% finished lower at D15, median -0.5% vs SPY -0.4%

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 2, 2026

Earnings came in 13.7% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 2, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.55-13.69% miss

-$0.48 expected

Revenue

$83.3M

SEC filing

EPS: Yahoo Finance

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 2, 2026	-$0.55est. -$0.48	-13.69%miss	$83.3MSEC filing	+81.6%from $45.9M
Jun 30, 2026Reported Aug 4, 2026	-$0.55est. -$0.45	-22.22%miss	$72.8MSEC filing	+91.8%from $38.0M
Mar 31, 2026Reported Apr 30, 2026	-$0.48est. -$0.59	+18.76%beat	$64.9MSEC filing	+223.6%from $20.0M
Dec 31, 2025Reported Feb 26, 2026	-$0.78est. -$0.64	-21.88%miss	$172.4M · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 3, 2025	-$0.70est. -$0.71	+1.54%beat	$45.9MSEC filing	+267.0%from $12.5M
Jun 30, 2025Reported Aug 4, 2025	-$0.83est. -$1.01	+17.82%beat	$38.0MSEC filing	+984.5%from $3.5M
Mar 31, 2025Reported May 5, 2025	Not on file	No estimate	$20.0MSEC filing	No year-ago quarter
Dec 31, 2024Reported Mar 3, 2025	-$1.10est. -$0.23	-$0.87miss	$23.7M · FYSEC filing	No year-ago quarter

Open: $9.59
High: $9.78
Low: $9.22
Prev close: $9.37
52-wk high: $25.59
52-wk low: $9.22
Mkt cap: $858.9M
ROE: -426.4%
Beta: 0.45
P/S: 3.0x
P/B: 84.8x
Profit margin: -72.3%
Op margin: -50.3%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -72.3%
Market cap: $859M

Valuation

P/S2.96
P/B84.75

Quality

Operating margin-50.3%
ROE-426.4%
ROA-17.9%

Growth

Beta0.45

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

32balanced

20D volatility

138%annualized

52-week range

$9.54

$9.22$25.59

20D support

$9.22recent floor

20D resistance

$16.95recent ceiling

Returns

5D -30.1%20D -43.8%60D -50.0%

Price vs moving averages

SMA20 -27.4%SMA50 -41.6%SMA200 -52.3%

Volume pace

2.11xvs prior 20D

Syndax Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about SNDX filings

Smart money on SNDX

Questions about SNDX filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 13.7% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Syndax Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about SNDX filings

Smart money on SNDX

Questions about SNDX filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 13.7% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Syndax Pharmaceuticals Inc

Overview

Questions about SNDX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Syndax Pharmaceuticals Inc

Overview

Questions about SNDX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.